D.E. Shaw & Co
REGN icon

D.E. Shaw & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$408M Buy
777,469
+198,580
+34% +$104M 0.29% 41
2025
Q1
$367M Buy
578,889
+78,659
+16% +$49.9M 0.33% 35
2024
Q4
$356M Buy
500,230
+233,994
+88% +$167M 0.26% 42
2024
Q3
$280M Buy
266,236
+11,821
+5% +$12.4M 0.24% 49
2024
Q2
$267M Buy
254,415
+23,944
+10% +$25.2M 0.25% 47
2024
Q1
$222M Sell
230,471
-133,587
-37% -$129M 0.19% 68
2023
Q4
$320M Sell
364,058
-6,363
-2% -$5.59M 0.28% 29
2023
Q3
$305M Buy
370,421
+82,642
+29% +$68M 0.32% 27
2023
Q2
$207M Buy
287,779
+136,446
+90% +$98M 0.21% 58
2023
Q1
$124M Buy
151,333
+135,038
+829% +$111M 0.13% 99
2022
Q4
$11.8M Sell
16,295
-21,130
-56% -$15.2M 0.01% 885
2022
Q3
$25.8M Sell
37,425
-26,903
-42% -$18.5M 0.03% 460
2022
Q2
$38M Sell
64,328
-135,375
-68% -$80M 0.04% 364
2022
Q1
$139M Sell
199,703
-93,168
-32% -$65.1M 0.13% 108
2021
Q4
$185M Buy
292,871
+120,736
+70% +$76.2M 0.15% 88
2021
Q3
$104M Buy
172,135
+119,119
+225% +$72.1M 0.09% 175
2021
Q2
$29.6M Buy
53,016
+32,316
+156% +$18M 0.03% 571
2021
Q1
$9.79M Sell
20,700
-34,958
-63% -$16.5M 0.01% 1019
2020
Q4
$26.9M Buy
55,658
+7,495
+16% +$3.62M 0.02% 584
2020
Q3
$27M Buy
48,163
+14,060
+41% +$7.87M 0.03% 507
2020
Q2
$21.3M Sell
34,103
-4,485
-12% -$2.8M 0.03% 547
2020
Q1
$18.8M Sell
38,588
-41,893
-52% -$20.5M 0.03% 504
2019
Q4
$30.2M Sell
80,481
-56,341
-41% -$21.2M 0.03% 445
2019
Q3
$38M Sell
136,822
-114,237
-46% -$31.7M 0.05% 363
2019
Q2
$78.6M Buy
251,059
+62,639
+33% +$19.6M 0.1% 199
2019
Q1
$77.4M Sell
188,420
-170,246
-47% -$69.9M 0.1% 185
2018
Q4
$134M Buy
358,666
+156,989
+78% +$58.6M 0.18% 91
2018
Q3
$81.5M Sell
201,677
-122,963
-38% -$49.7M 0.1% 196
2018
Q2
$112M Sell
324,640
-333,070
-51% -$115M 0.15% 129
2018
Q1
$226M Buy
657,710
+122,000
+23% +$42M 0.31% 54
2017
Q4
$201M Buy
535,710
+446,025
+497% +$168M 0.28% 51
2017
Q3
$40.1M Buy
89,685
+29,937
+50% +$13.4M 0.06% 295
2017
Q2
$29.3M Buy
59,748
+52,645
+741% +$25.9M 0.05% 356
2017
Q1
$2.75M Sell
7,103
-1,696
-19% -$657K ﹤0.01% 1235
2016
Q4
$3.23M Buy
8,799
+2,529
+40% +$928K 0.01% 1169
2016
Q3
$2.52M Sell
6,270
-14,240
-69% -$5.73M ﹤0.01% 1254
2016
Q2
$7.16M Sell
20,510
-99,059
-83% -$34.6M 0.01% 823
2016
Q1
$43.1M Sell
119,569
-2,104
-2% -$758K 0.08% 238
2015
Q4
$66.1M Sell
121,673
-15,456
-11% -$8.39M 0.1% 184
2015
Q3
$63.8M Buy
137,129
+77,508
+130% +$36.1M 0.09% 208
2015
Q2
$30.4M Sell
59,621
-32,132
-35% -$16.4M 0.05% 366
2015
Q1
$41.4M Sell
91,753
-17,187
-16% -$7.76M 0.06% 281
2014
Q4
$44.7M Sell
108,940
-34,642
-24% -$14.2M 0.06% 258
2014
Q3
$51.8M Buy
143,582
+66,305
+86% +$23.9M 0.07% 218
2014
Q2
$21.8M Buy
77,277
+13,753
+22% +$3.88M 0.03% 396
2014
Q1
$19.1M Sell
63,524
-63,277
-50% -$19M 0.03% 428
2013
Q4
$34.9M Buy
126,801
+23,970
+23% +$6.6M 0.05% 272
2013
Q3
$32.2M Buy
102,831
+101,631
+8,469% +$31.8M 0.05% 250
2013
Q2
$270K Buy
+1,200
New +$270K ﹤0.01% 2076